Always verify pricing and state availability on the provider's website before signing up.How our reviews work →

9amHealth vs Embody

An in-depth comparison of two leading GLP-1 Providers

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

7.6

9amHealth

Best for Insured patients wanting branded GLP-1s within a full cardiometabolic care program
★★★3.8

Starting at $149/mo

Branded GLP-1WegovyZepboundSaxenda
Visit 9amHealth
8.5

Embody

Best for lowest first-month entry pricing on compounded GLP-1s
★★★★4.3

Starting at $99/mo

CompoundedOral OptionSemaglutideTirzepatide
Visit Embody

Side-by-Side Comparison

Feature9amHealthEmbody
Overall Score7.6/108.5/10
Starting Price$149/mo$99/mo
Editorial Rating3.8 ★ /54.3 ★ /5
Features7 features6 features
States Available00
Compounded✓ Yes
Brand Name✓ Yes
FSA/HSA Accepted
FDA WarningsNoneNone

Pros & Cons

9amHealth

Pros

  • Prescribes FDA-approved branded GLP-1s (Wegovy, Zepbound, Saxenda)
  • $149/month membership or free when covered by insurance
  • Membership includes specialists, labs, devices, and medications
  • Board-certified obesity specialists (DABOM), endocrinologists, dietitians, PharmDs
  • Helps navigate insurance approvals; employer and state-plan partnerships
  • Home lab draws available in some areas
  • Cardiometabolic whole-body care beyond weight loss

Cons

  • Medication coverage and GLP-1 access depend on insurance and BMI criteria
  • State availability not enumerated on the public site
  • Branded GLP-1s can be costly without insurance coverage
  • Pricing for medications not transparently listed

Embody

Pros

  • Lowest first-month entry pricing in the compounded segment ($99 first month for semaglutide, $149 for tirzepatide injection)
  • Unique compounded oral tirzepatide gum formulation — alternative for patients who prefer not to inject
  • Available in all 50 states with no insurance friction
  • 24/7 unlimited clinician messaging and dose-adjustment support included
  • Medical leadership by Dr. Alan Viglione, board-certified in Internal Medicine

Cons

  • Refill pricing jumps to $299/month after the first month — initial $99/$149 is an intro rate, not the ongoing cost
  • Compounded only — no FDA-approved brand-name Ozempic, Wegovy, Zepbound, or Mounjaro option
  • Pharmacy partners not publicly named — compounding source transparency is limited
  • Compounded oral tirzepatide does not have an FDA-approved counterpart, and oral GLP-1 bioavailability remains an active area of clinical debate

Our Verdict

Winner: EmbodyScore: 8.5/10

Embody edges out 9amHealth with a higher overall score of 8.5/10 and is particularly strong for lowest first-month entry pricing on compounded GLP-1s. 9amHealth remains a solid alternative, especially if you're looking for Insured patients wanting branded GLP-1s within a full cardiometabolic care program.

Glossary references

Key terms in this article, linked to their canonical definitions.

Related comparisons

Continue exploring 9amHealth and Embody head-to-heads in the same category.

Or see the full category ranking.

Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.